ATE396178T1 - Verfahren zur herstellung von aripiprazol, und entsprechende zwischenprodukte und deren herstellung - Google Patents
Verfahren zur herstellung von aripiprazol, und entsprechende zwischenprodukte und deren herstellungInfo
- Publication number
- ATE396178T1 ATE396178T1 AT04791863T AT04791863T ATE396178T1 AT E396178 T1 ATE396178 T1 AT E396178T1 AT 04791863 T AT04791863 T AT 04791863T AT 04791863 T AT04791863 T AT 04791863T AT E396178 T1 ATE396178 T1 AT E396178T1
- Authority
- AT
- Austria
- Prior art keywords
- aripiprazole
- reacting
- novel
- preparation
- production
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004372 aripiprazole Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 2
- 239000013067 intermediate product Substances 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 5
- MOANRQDXNNXOLW-UHFFFAOYSA-N 6-hydroxyindanone Natural products OC1=CC=C2CCC(=O)C2=C1 MOANRQDXNNXOLW-UHFFFAOYSA-N 0.000 abstract 3
- DXEOJRJYNSFSFL-UHFFFAOYSA-N 6-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2,3-dihydroinden-1-one Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4C(=O)CCC4=CC=3)CC2)=C1Cl DXEOJRJYNSFSFL-UHFFFAOYSA-N 0.000 abstract 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0239—Quaternary ammonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2004/000316 WO2006038220A1 (en) | 2004-10-08 | 2004-10-08 | Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396178T1 true ATE396178T1 (de) | 2008-06-15 |
Family
ID=34959292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04791863T ATE396178T1 (de) | 2004-10-08 | 2004-10-08 | Verfahren zur herstellung von aripiprazol, und entsprechende zwischenprodukte und deren herstellung |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7872132B2 (de) |
| EP (1) | EP1812395B1 (de) |
| JP (1) | JP4819818B2 (de) |
| KR (1) | KR101041551B1 (de) |
| CN (1) | CN101068789B (de) |
| AT (1) | ATE396178T1 (de) |
| AU (1) | AU2004323810B2 (de) |
| CA (1) | CA2584789C (de) |
| DE (1) | DE602004014041D1 (de) |
| EA (1) | EA012180B1 (de) |
| IL (1) | IL182439A (de) |
| NZ (1) | NZ554731A (de) |
| WO (1) | WO2006038220A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008026220A1 (en) * | 2006-08-28 | 2008-03-06 | Lupin Limited | A process for purification of 7-(4-bromobutoxy)-3,4 dihydrocarbostyril, an intermediate for manufacture of aripirazole |
| RU2497819C2 (ru) | 2007-05-21 | 2013-11-10 | Ривайва Фармасьютикалс, Инк. | Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина |
| CN101323590B (zh) * | 2007-06-15 | 2011-07-20 | 成都弘达药业有限公司 | 阿立哌唑的合成方法及其中间体 |
| KR101340214B1 (ko) * | 2011-03-31 | 2013-12-10 | 주식회사 대웅제약 | 무수 아리피프라졸 ⅱ형 결정의 제조방법 |
| KR101251561B1 (ko) | 2012-08-13 | 2013-04-08 | 주식회사 삼오제약 | 아리피프라졸의 제조에 유용한 신규 중간체, 이의 제조방법 및 이를 이용한 아리피프라졸의 제조 방법 |
| US10882816B2 (en) * | 2017-08-09 | 2021-01-05 | Lonza Ltd | Method for the preparation of 4-(heptafluoro-2-propyl) anilines |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB850663A (en) | 1956-10-22 | 1960-10-05 | Parke Davis & Co | Substituted piperazines and process for their production |
| DE3026331A1 (de) * | 1980-07-11 | 1982-02-18 | Basf Ag, 6700 Ludwigshafen | Indanon-oxyalkyl-piperazinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitung |
| ES8601148A1 (es) * | 1984-12-10 | 1985-11-16 | Ferrer Int | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. |
| US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| JP4902945B2 (ja) * | 2003-01-09 | 2012-03-21 | 大塚製薬株式会社 | アリピプラゾールの製造法 |
| TWI258470B (en) * | 2003-01-09 | 2006-07-21 | Otsuka Pharma Co Ltd | Process for preparing aripiprazole |
| US20080299216A1 (en) * | 2007-06-01 | 2008-12-04 | Protia, Llc | Deuterium-enriched aripiprazole |
-
2004
- 2004-10-08 KR KR1020077010187A patent/KR101041551B1/ko not_active Expired - Fee Related
- 2004-10-08 AU AU2004323810A patent/AU2004323810B2/en not_active Ceased
- 2004-10-08 CN CN2004800445194A patent/CN101068789B/zh not_active Expired - Fee Related
- 2004-10-08 JP JP2007535326A patent/JP4819818B2/ja not_active Expired - Fee Related
- 2004-10-08 CA CA2584789A patent/CA2584789C/en not_active Expired - Fee Related
- 2004-10-08 US US11/664,849 patent/US7872132B2/en not_active Expired - Fee Related
- 2004-10-08 AT AT04791863T patent/ATE396178T1/de not_active IP Right Cessation
- 2004-10-08 WO PCT/IN2004/000316 patent/WO2006038220A1/en not_active Ceased
- 2004-10-08 EP EP04791863A patent/EP1812395B1/de not_active Expired - Lifetime
- 2004-10-08 NZ NZ554731A patent/NZ554731A/en not_active IP Right Cessation
- 2004-10-08 DE DE602004014041T patent/DE602004014041D1/de not_active Expired - Lifetime
- 2004-10-08 EA EA200700816A patent/EA012180B1/ru not_active IP Right Cessation
-
2007
- 2007-04-10 IL IL182439A patent/IL182439A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL182439A0 (en) | 2007-07-24 |
| KR20070073878A (ko) | 2007-07-10 |
| WO2006038220A1 (en) | 2006-04-13 |
| EA200700816A1 (ru) | 2007-10-26 |
| DE602004014041D1 (de) | 2008-07-03 |
| US7872132B2 (en) | 2011-01-18 |
| KR101041551B1 (ko) | 2011-06-15 |
| EP1812395A1 (de) | 2007-08-01 |
| CN101068789A (zh) | 2007-11-07 |
| JP2008515879A (ja) | 2008-05-15 |
| EA012180B1 (ru) | 2009-08-28 |
| AU2004323810A1 (en) | 2006-04-13 |
| AU2004323810B2 (en) | 2011-11-17 |
| EP1812395B1 (de) | 2008-05-21 |
| IL182439A (en) | 2011-04-28 |
| JP4819818B2 (ja) | 2011-11-24 |
| NZ554731A (en) | 2009-12-24 |
| CA2584789C (en) | 2010-11-23 |
| US20090203907A1 (en) | 2009-08-13 |
| CN101068789B (zh) | 2010-12-15 |
| CA2584789A1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50307267D1 (de) | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| BRPI0417052A (pt) | processo para a preparação de compostos | |
| DE602008004649D1 (de) | Anthranilsäure-derivat als antikrebswirkstoff und verfahren zur herstellung davon | |
| IL182439A0 (en) | Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole | |
| JPH0768216B2 (ja) | 置換されたピリジン−２，３−ジカルボキシレ−トエステル類の製造法 | |
| ATE444747T1 (de) | Verfahren zur herstellung von expoxybutanol- zwischenprodukten | |
| JP4389205B2 (ja) | ４−アミノキナゾリン化合物の製法 | |
| ATE373009T1 (de) | Verfahren zur vorbereitung von telithromycin | |
| SG158864A1 (en) | Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1- carboxylic acid derivatives and related compounds | |
| NO20063989L (no) | Fremgangsmater for a produsere 3-O-beskyttede morfinoner og 3-O-beskyttede morfinondienol-karboksylater | |
| ATE496907T1 (de) | Verfahren zur herstellung von cilostazol | |
| ATE546432T1 (de) | Verfahren zur herstellung von 2- aminomethylpyridin-derivate | |
| JP2762430B2 (ja) | アラルキルアミノピリミジン類の製法 | |
| DE50310200D1 (de) | Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte | |
| ATE443089T1 (de) | Aminotriazin-kondensationsprodukt, verwendung eines aminotriazin-kondensationsproduktes und verfahren zur herstellung des aminotriazin- kondensationsproduktes | |
| ATE353877T1 (de) | Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern | |
| DE60112241D1 (de) | Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen | |
| ATE471312T1 (de) | Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung | |
| ATE482920T1 (de) | Halogenphenylderivatzwischen produkte und deren verwendung in einem verfahren zur herstellung von azolderivaten | |
| Xing et al. | Synthesis and Structure of Novel 4‐Arylamino‐2‐phenyl‐6‐substituted‐quinazoline | |
| ATE501158T1 (de) | Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| BRPI0508996A (pt) | processo para preparação de derivados de n-aril-piperazina | |
| ATE444964T1 (de) | 5-pyridinyl-1-azabicycloä3.2.1üoctan-derivate, herstellungsverfahren und deren verwendung für therapeutika | |
| MY126252A (en) | Process for the preparation of (3-cyano-1h-indol-7-yl) [4-(4-fluorophenethyl) piperazin-1-yl] methanone and salts thereof | |
| ATE183507T1 (de) | Verfahren zur herstellung von 2-(4-(4-(4-chloro-1-pyrazolyl)butyl)1-piperazin l)pyrimidin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |